Rating History for Amylin Pharmaceuticals (AMLN) by MKM Partners

More Stocks Rated by MKM Partners | Latest Ratings for AMLN
Date Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
3/29/2012 Upgrade Neutral
(N/A)		 22.00
(N/A)		 23.77 30.98 30.33% Details
1/11/2012 Downgrade Sell
(N/A)		 N/A
(N/A)		 11.17 23.77 112.8% Details
6/24/2011 New Coverage Neutral
(N/A)		 N/A
(N/A)		 12.12 11.17 -7.84% Details